학술논문

Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study
Document Type
article
Source
Molecular Psychiatry. 20(10)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Mental Health
Sleep Research
Clinical Research
Brain Disorders
Genetics
Human Genome
2.1 Biological and endogenous factors
Aetiology
Good Health and Well Being
Adult
Black or African American
Aged
Dyssomnias
Female
Genetic Association Studies
Genome-Wide Association Study
Humans
Male
Middle Aged
Polymorphism
Single Nucleotide
Self Report
Sleep
White People
Biological Sciences
Medical and Health Sciences
Psychology and Cognitive Sciences
Psychiatry
Clinical sciences
Biological psychology
Clinical and health psychology
Language
Abstract
Usual sleep duration is a heritable trait correlated with psychiatric morbidity, cardiometabolic disease and mortality, although little is known about the genetic variants influencing this trait. A genome-wide association study (GWAS) of usual sleep duration was conducted using 18 population-based cohorts totaling 47 180 individuals of European ancestry. Genome-wide significant association was identified at two loci. The strongest is located on chromosome 2, in an intergenic region 35- to 80-kb upstream from the thyroid-specific transcription factor PAX8 (lowest P=1.1 × 10(-9)). This finding was replicated in an African-American sample of 4771 individuals (lowest P=9.3 × 10(-4)). The strongest combined association was at rs1823125 (P=1.5 × 10(-10), minor allele frequency 0.26 in the discovery sample, 0.12 in the replication sample), with each copy of the minor allele associated with a sleep duration 3.1 min longer per night. The alleles associated with longer sleep duration were associated in previous GWAS with a more favorable metabolic profile and a lower risk of attention deficit hyperactivity disorder. Understanding the mechanisms underlying these associations may help elucidate biological mechanisms influencing sleep duration and its association with psychiatric, metabolic and cardiovascular disease.